Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Action: Physiological Effects

Effect of Metronidazole on the Pathogenicity of Resistant Bacteroides Strains in Gnotobiotic Mice

Claudio Galuppo Diniz, Denise Carmona Cara, Jacques Robert Nicoli, Luiz De Macedo Farias, Maria Auxiliadora Roque De Carvalho
Claudio Galuppo Diniz
Departamento de Microbiologia and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denise Carmona Cara
Departamento de Patologia Geral, ICB-UFMG, 30.161-970 Belo Horizonte, MG, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacques Robert Nicoli
Departamento de Microbiologia and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luiz De Macedo Farias
Departamento de Microbiologia and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Auxiliadora Roque De Carvalho
Departamento de Microbiologia and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.44.9.2419-2423.2000
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Metronidazole is widely used to treat protozoan and fungal infections. As an antibacterial drug, it is used mainly against anaerobes. Among anaerobes, the Bacteroides fragilis group is the most relevant in terms of frequency of recovery and antimicrobial resistance patterns. The use of metronidazole and other antimicrobial drugs induces morphological changes in this bacterial group. The present study investigated in vivo if these morphological modifications were accompanied by changes in virulence patterns by using germfree mice experimentally challenged with metronidazole-resistant Bacteroides strains before and after exposure to metronidazole. It was observed that metronidazole-resistant strains were more virulent after contact with the drug, as demonstrated by anatomicopathologic data for spleen, liver, and small intestine samples. These results suggest that long-term therapy and high metronidazole concentrations could interfere with microbial pathogenicity, resulting in changes to host-bacterium relationships.

Anaerobic bacteria are an evolutionarily and ecologically significant group. Their ability to survive under diverse conditions and versatility give them the status of amphibiotic organisms (9). Species of theBacteroides fragilis group emerge as the predominant microorganisms in the normal microbiota of humans and other mammals and constitute one-third of the pathogens isolated from anaerobic infections. These infections are characterized mainly by intra-abdominal and pulmonary abscesses and other kinds of infections, including septicemia (9). The bacteria's virulence has mainly been related to cell surface compounds, such as the outer capsular polysaccharide envelope and outer membrane lipopolysaccharide, as well as to the production of hydrolytic enzymes and exotoxin (22).

Nowadays, metronidazole (2-methyl-5-nitroimidazole-1-ethanol) is widely used to treat protozoan diseases and against mainly anaerobic bacteria, including Bacteroides (10). Under anaerobic conditions, 5-nitroimidazoles are reduced to cytotoxic nitroradicals, which have been shown to act by inactivating DNA and other cell components (5).

Since 1940, many authors have observed that gram-positive rods exposed to low concentrations of penicillin and other antimicrobial agents show altered morphology indicative of aberrant bacterial cells (11). Later it was demonstrated that such aberrant cells could also occur among treated gram-negative bacteria and yeasts (16, 19). In the B. fragilis group, the occurrence of aberrant cell shape caused by previous treatment with low or high concentrations of antimicrobial drugs such as metronidazole has been also described as indicative of altered cellular properties (4, 24). It has been suggested that these changes in cell shape could lead to eventual differences in the virulence properties of microorganisms and in their relationships with host immunodefenses (16).

The objective of the present study was to investigate in vivo whether previous treatment with high concentrations of metronidazole may be capable of inducing any change in the virulence profile of metronidazole-resistant Bacteroidescells isolated from human clinical specimens and from the gastrointestinal tracts of healthy marmosets, using germfree mice as a study model.

MATERIALS AND METHODS

Bacterial strains.Two metronidazole-resistant strains identified with the API 20A kit (BioMérieux S.A., Marcy l'Etoile, France) as Bacteroides distasonis were used. One of them was isolated from a human intra-abdominal abscess (RH), and the other was isolated from the gastrointestinal tract of a healthy marmoset (Callithrix penicillata) (RM). Both of them were metronidazole resistant (the MIC at which 90% of the isolates tested were inhibited was 256 μg/ml for RH and 512 μg/ml for RM) according to the agar dilution test and were stored at −86°C in our culture collection. They were divided into four groups distinguished by maintenance in the presence of (RHmzol and RMmzol) or absence (RH and RM) of metronidazole. The strains were grown in 5 ml of brain heart infusion supplemented with hemin, menadione, and yeast extract (BHI-S), either containing or not containing 200 μg of metronidazole (lot no. 54H0407; Sigma Chemical Company, St. Louis, Mo.)/ml. The bacteria were grown for 24 h at 37°C in an anaerobic chamber (Forma Scientific Inc., Marietta, Ohio) containing an atmosphere of 85% N2, 10% H2, and 5% CO2.

Animals.Germfree NIH (Taconic, Germantown, N.Y.) 21-day-old mice were used in this study. The animals were housed in flexible plastic isolators (Standard Safety Company, Palatine, Ill.) and were handled according to established procedures (20). The animals were fed an autoclavable commercial diet for rodents (Nuvital, Curitiba, Brazil). Experiments with gnotobiotic mice were carried out in microisolators (UNO Roestvastaal B.V., Zevenaar, The Netherlands).

Experimental challenge.Thirty germfree mice were divided into five experimental groups of six animals. Each group was designated as follows, according to the associated bacterial strain: group 1, RHmzol, group 2, RH; group 3, RMmzol, group 4, RM; and group 5, control germfree. The groups were inoculated intragastrically with 0.1 ml of anaerobically grown (for 24 h) suspensions in BHI-S of RHmzol, RMmzol, RH, and RM which contained about 108 CFU/ml.

Microbial counts in gnotobiotic groups.Feces collected by anal stimulation from all mice every 72 h after the challenge were introduced into the anaerobic chamber, diluted 100-fold in regenerated sterile buffered saline (pH 7.4), and homogenized by hand. Serial 10-fold dilutions were obtained, and 0.1-ml amounts were plated onto BHI agar supplemented with hemin, menadione, and yeast extract (BHI agar-S). The petri dishes were incubated for 48 h in the anaerobic chamber at 37°C, after which colonies were counted. The monoxenic (groups 1, 2, 3, and 4) or germfree (group 5) status of the animals was regularly tested, and metronidazole resistance was reevaluated after recovering the Bacteroides strains from mouse feces (BHI agar-S containing 200 μg of metronidazole/ml).

Histopathologic evaluation.All experimental and control animals were sacrificed by ether inhalation and necropsied after 14 days of infection. Spleen, liver, and small intestine samples were excised and evaluated macroscopically. Small intestine samples were identified as duodenum, proximal jejunum, distal jejunum, and ileum according to established procedures (7). Fragments of spleen, liver, and small intestine were fixed in formaldehyde–phosphate-buffered saline (1:10, pH 7.2) and dehydrated in alcoholic solution by using an automated tissue processor (Titertek Autotechnicon, Technicon tissue processor no. 2A; The Technicon Company, Chauncey, N.Y.). The fragments were embedded in paraffin, and 4-μm cross sections were obtained with a microtome (no. 820; Spencer, Buffalo, N.Y.). The slides were stained with hematoxylin and eosin, coded, and examined by a single pathologist, who was unaware of the experimental conditions for each group.

Statistical analysis.Some data were evaluated by analysis of variance. Statistical analysis was performed with EPISTAT software (T. L. Gustafson, Round Rock, Tex.), with the level of significance set at a value of P < 0.05.

RESULTS

We observed that during and after metronidazole exposure, the samples (RHmzol and RMmzol) showed altered morphology with filamentous cell formation (Fig.1).

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Gram stain of B. distasonis cells before and after metronidazole exposure. (A) Human (left) and marmoset (right) strains before drug exposure; (B) Human (left) and marmoset (right) strains after metronidazole maintenance (200 μg/ml). Original magnification, ×1,000.

Figure 2 shows that theBacteroides strains became established in the digestive tracts of all experimental gnotobiotic groups and that the number of CFU was about 109/g of feces.

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

Bacterial population levels in the feces of germfree NIH mice intragastrically challenged with B. distasonis strains previously treated (RHmzol and RMmzol) or not (RH and RM) with metronidazole.

The macroscopic examination of livers from animals infected with all the Bacteroides strains did not show any apparent alteration. Spleens from mice infected with the RHmzolstrain proved to be seriously damaged. Significant atrophy was observed when they were compared with spleens from animals infected with RMmzol, RH, and RM and from the control group (Fig.3). Analysis of variance of the spleen areas showed that this atrophy was statistically significant (P < 0.05). Macroscopic examination of the small intestine showed hemorrhagic areas in the duodenum and proximal jejunum.

Fig. 3.
  • Open in new tab
  • Download powerpoint
Fig. 3.

Mean areas of the spleens from germfree (control) and gnotobiotic mice infected for 14 days with B. distasonisstrains previously treated (RHmzol and RMmzol) or not (RH and RM) with metronidazole. Different letters above bars indicate that results were significantly different (P< 0.05).

Histopathologic examination of spleen, liver, and intestine samples confirmed the macroscopic data, showing significant lesions in the animals infected with the RHmzol and RMmzolstrains. Lesions or alterations were not observed in the group infected with the RH and RM strains or in the control group. The intestinal lesions were markedly expressed as altered villi with erythrocytes in the mucous tissue and congested blood vessels (Fig.4). These lesions, however, were more evident in the animals infected with the RHmzol strain. Microscopically, livers from animals infected with RHmzoland RMmzol showed some hemorrhagic areas with congested blood vessels. The same was not observed in the animals infected with the RH and RM strains or in the control group. In spleens from mice infected with the RHmzol strain, a reduction of the lymphoid component and red pulp was observed when those spleens were compared with spleens from animals infected with RMmzol, RH, and RM and from the control group (Fig.5).

Fig. 4.
  • Open in new tab
  • Download powerpoint
Fig. 4.

Histological examination of small intestine mucosae from gnotobiotic mice infected for 14 days with resistant B. distasonis strains not treated (RH [A]) or previously treated (RHmzol [B]) with metronidazole. White arrows show the appearance of blood vessels (normal [A] and congested [B]). Black arrows (B) indicate mucosal hyperhemia, showing blood cells at the basal mucosa of intestine from an animal challenged with RHmzol. Interestingly, strain RMmzol behaved very similarly to RHmzol. Hematoxylin and eosin were applied. Original magnification, ×240.

Fig. 5.
  • Open in new tab
  • Download powerpoint
Fig. 5.

Histological examination of the spleen from gnotobiotic mice infected for 14 days with B. distasonis strains previously treated (RHmzol [A] and RMmzol[B]) or not (RH [C] and RM [D]) with metronidazole. Dark areas on photomicrographs indicate red pulp, and light areas indicate white pulp. Hematoxylin and eosin were applied. Original magnification, ×46.

DISCUSSION

There is a delicate balance in the intestine among the number of microbes and their virulence characteristics and the immune status of the host. Infection occurs whenever a microbe, whether by exposing the host to a larger infective dose or by increasing its own virulence characteristics, manages to disrupt the balance in its favor. Many of the bacteria in the gastrointestinal ecosystem, especially gram-negative rods, are opportunistic pathogens and are capable of eliciting injurious, proinflammatory responses if viable bacteria or soluble cell surface components or metabolic products interact with cells of the immune system (12). This indigenous microbiota may be pathogenic during an eventual disequilibrium of the digestive ecosystem or when these microorganisms are introduced into sterile areas of the body (3, 25). This disequilibrium may be due to immunosuppression, infectious or noninfectious diseases, or long-term therapy with antimicrobial agents.

Virulence factors may vary among individuals in the same microbial population. Thus, any agent that can interfere with their genetic profiles may influence the initial virulence properties of this population (16). In the B. fragilis group, the virulence has mainly been related to capsular polysaccharide, lipopolysaccharide, hydrolytic enzymes, and exotoxin (22). Various studies have indicated that short-chain fatty acids are also important virulence factors which affect the host defense mechanisms. Butyric acid, in particular, inhibits T-cell proliferation induced by different mitogenic stimuli (13).

Since the early 1940s many authors have observed morphological changes in various microbial species in the presence of different antimicrobial agents. In almost all cases these alterations are related to differences in the virulence patterns of such microorganisms (8, 11, 15, 23). In various studies, elongated cells of B. fragilis were observed in the presence of metronidazole, as was the case with B. distasonis strains during and after metronidazole exposure in this study. Elongation appears to result from the inhibition of autolytic enzymes that initiate separation. Nevertheless, the extent and consequences of these aberrant forms for the virulence properties of the B. fragilis group are unclear.

It has been previously demonstrated that antimicrobial agents are capable of interfering with the adhesiveness and enzyme and toxin production of different microbial groups. The β-lactams, quinolones, tetracyclines, glycopeptides, macrolides, lincosamides, and nitroimidazoles may stimulate adhesiveness to both epithelial and intestinal cells and the production of hemolysin, penicillinases, enterotoxins, other toxins, and enzymes by different species, such asStaphylococcus aureus, Streptococcus pyogenes,Streptococcus pneumoniae, Escherichia coli,Vibrio cholerae, Clostridium difficile, andB. fragilis (8, 14, 15, 17, 21, 26, 27). The enhancement of surface anionogenicity and hydrophobicity ofBacteroides by metronidazole, as an example, may allow the bacteria to approach negatively charged surfaces of animal cells more efficiently.

In this study, the metronidazole-resistant strains showed differences in host-microbial interaction after exposure to metronidazole. RHmzol and RMmzol were more pathogenic, as shown by the histopathologic data. However, RHmzol was more virulent and had an unexpected and strong effect on the spleen in particular, which atrophied during the infection. It is well established that red pulp may function as a blood reserve. The atrophy of this spleen component may be related to hemorrhagic processes like that observed in the intestines of animals challenged with metronidazole-resistant strains maintained in the presence of this drug. On the other hand, white pulp is comprised of lymphnodes and should grow during the acute immune response. However, during immunosuppression, these lymphnodes generally undergo degeneration by cellular apoptosis, which causes a reduction in the size of most lymphoid organs (mainly the spleen) (2). This pattern also establishes the interference of anaerobic bacteria with the host's immune response, acting as lymphocyte suppressor agents (6).

The present results suggest that antibiotic resistance in microorganisms leads to an increase in morbidity and mortality not only by increasing the risk of inappropriate therapy but also by simultaneously increasing the virulence of such resistant microorganisms. Further prospective clinical, pathological, and immunological investigations are needed to elucidate the level of interference of metronidazole and other antimicrobial agents, mainly in the remaining susceptible and indigenous microorganisms, as established by the American Society for Microbiology (1) and by the European Societies of Health (18).

ACKNOWLEDGMENTS

We are grateful to Wanderlany Amâncio Martins, Rinaldo Duarte, and Andréia Marçal da Silva for their help in the experiments with germfree animals and to Francisco José Neves Júnior, Luzia Rosa Rezende, and Maria Gorete Barbosa Ribas for technical help.

We thank CNPq and FAPEMIG for infrastructure and research fellowships.

FOOTNOTES

    • Received 31 January 2000.
    • Returned for modification 31 March 2000.
    • Accepted 7 June 2000.
  • Copyright © 2000 American Society for Microbiology

REFERENCES

  1. 1.↵
    ASM Task Force on Antibiotic Resistance Report of the ASM Task Force on Antibiotic Resistance. 1995 American Society for Microbiology Washington, D.C.
  2. 2.↵
    1. Barret J. T.
    An introduction to immunochemistry and immunobiology 3rd ed. 1978 The C. V. Mosby Company St. Louis, Mo
  3. 3.↵
    1. Broock T. D.
    Principles of microbial ecology. 1986 Prentice-Hall, Inc. Englewood Cliffs, N.J
  4. 4.↵
    1. Cavalcanti S. M. B.,
    2. Domingues R. M. C. P.,
    3. Ferreira M. C. S.,
    4. Costa e Silva F. Jr.
    Effect of metronidazole on surface properties of Bacteroides fragilis. J. Antimicrob. Chemother. 28 1991 819 826
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Edwards D. I.
    Nitroimidazole drugs—action and resistance mechanisms. I. Mechanism of action. J. Antimicrob. Chemother. 31 1993 9 20
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Eftimiadi C.,
    2. Stashenko P.,
    3. Tonetti M.,
    4. Mangiante P. E.,
    5. Massara R.,
    6. Zupo S.,
    7. Ferrarini M.
    Divergent effect of the anaerobic bacteria by-product butyric acid on the immune response: suppression of T-lymphocyte proliferation and stimulation of interleukin-1 beta production. Oral Microbiol. Immunol. 6 1991 17 23
    OpenUrlPubMed
  7. 7.↵
    1. Ferraris R. P.,
    2. Villenas S. A.,
    3. Diamond J.
    Regulation of brush-border enzyme activities and enterocyte migration rates in mouse small intestine. Am. J. Physiol. 262 1992 G1047 G1059
    OpenUrlPubMed
  8. 8.↵
    1. Ferreira M. C.,
    2. Domingues M. C. P.,
    3. de Uzeda M.
    Influence of metronidazole, chloramphenicol, clindamycin and penicillin G on growth and neuraminidase activity of Bacteroides fragilis. J. Antimicrob. Chemother. 24 1989 157 164
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Finegold S. M.
    Anaerobes: problems and controversies in bacteriology, infections and susceptibility testing. Rev. Infect. Dis. 12 1990 223 230
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Freeman C. D.,
    2. Klutman N. E.,
    3. Lamp K. C.
    Metronidazole: a therapeutic review and update. Drugs 54 1997 679 708
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Giesbrecht P.,
    2. Kersten T.,
    3. Maidhof H.,
    4. Wecke J.
    Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin. Microbiol. Mol. Biol. Rev. 62 1998 1371 1414
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Hooper I. V.,
    2. Bry I.,
    3. Falk P. G.,
    4. Gordon J. I.
    Host-microbial symbiosis in the mammalian intestine: exploring an internal ecosystem. Bioessays 20 1998 236 243
    OpenUrl
  13. 13.↵
    1. Kyner D.,
    2. Zabos P.,
    3. Christman J.,
    4. Acs G.
    Effect of sodium butyrate on lymphocyte activation. J. Exp. Med. 144 1976 1674 1678
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Levner M.,
    2. Wiener F. P.,
    3. Rubin B. A.
    Induction of Escherichia coli and Vibrio cholerae enterotoxins by an inhibitor of protein synthesis. Infect. Immun. 15 1977 132 137
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Lorian V.
    Effect of antibiotics on staphylococcal hemolysin production. Appl. Microbiol. 22 1971 106 109
    OpenUrlPubMed
  16. 16.↵
    1. Lorian V.,
    2. Gemmell C. G.
    Effect of low antibiotic concentrations on bacteria: effects on ultrastructure, virulence, and susceptibility to immune defenses Antibiotics in laboratory medicine. Lorian V. 1994 493 549 The Williams & Wilkins Co. Baltimore, Md
  17. 17.↵
    1. Lorian V.,
    2. Waluschka A.,
    3. Kim Y.
    Abnormal morphology of bacteria in the sputa of patients treated with antibiotics. J. Clin. Microbiol. 16 1982 382 386
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Monnet D. L.
    European recommendations to respond to the threat of antimicrobial-resistant microorganisms. ASM News 65 1999 390 391
    OpenUrl
  19. 19.↵
    1. Nosanchuk J. D.,
    2. Cleare W.,
    3. Franzot S. P.,
    4. Casadevall A.
    Amphotericin B and fluconazole affect cellular charge, macrophage phagocytosis, and cellular morphology of Cryptococcus neoformans at subinhibitory concentrations. Antimicrob. Agents Chemother. 43 1999 233 239
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Pleasants J. R.
    Gnotobiotics Handbook of laboratory animal science. Melby E. C. Jr., Altmann N. H. 1974 119 174 CRC Press Cleveland, Ohio
  21. 21.↵
    1. Proctor R. A.,
    2. Olbrantz P. J.,
    3. Mosher D. F.
    Subinhibitory concentrations of antibiotics alter fibronectin binding to Staphylococcus aureus. Antimicrob. Agents Chemother. 24 1983 823 826
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Rokosz A.,
    2. Meisel-Mikolajczyk F.
    Selected properties of Bacteroides fragilis enterotoxigenic strains. Med. Dosw. Mikrobiol. 47 1995 183 188 (In Polish.)
    OpenUrlPubMed
  23. 23.↵
    1. Settle C. D.,
    2. Wilcox M. H.
    Review article: antibiotic-induced Clostridium difficile infection. Aliment. Pharmacol. Ther. 10 1996 835 841
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Takahata M.,
    2. Nishino T.
    Antibacterial activities of tosufloxacin against anaerobic bacteria and the electron micrograph of its bactericidal effects. Chemotherapy 43 1997 153 158
    OpenUrlPubMed
  25. 25.↵
    1. Tannock G. W.
    The normal microflora: new concepts in health promotion. Microbiol. Sci. 5 1988 4 8
    OpenUrlPubMed
  26. 26.↵
    1. Vosbeck V.
    Effects of low concentrations of antibiotics on Escherichia coli adhesion The influence of antibiotics on the host-parasite relationship. Eickenberg H. U., Hahn H., Opferkuch W. 1982 183 192 Springer-Verlag New York, N.Y
  27. 27.↵
    1. Yoh M.,
    2. Yamamoto K.,
    3. Honda T.,
    4. Takeda Y.,
    5. Miwatani T.
    Effects of lincomycin and tetracycline on production and properties of enterotoxins of enterotoxigenic Escherichia coli. Infect. Immun. 42 1983 778 782
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Effect of Metronidazole on the Pathogenicity of Resistant Bacteroides Strains in Gnotobiotic Mice
Claudio Galuppo Diniz, Denise Carmona Cara, Jacques Robert Nicoli, Luiz De Macedo Farias, Maria Auxiliadora Roque De Carvalho
Antimicrobial Agents and Chemotherapy Sep 2000, 44 (9) 2419-2423; DOI: 10.1128/AAC.44.9.2419-2423.2000

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Effect of Metronidazole on the Pathogenicity of Resistant Bacteroides Strains in Gnotobiotic Mice
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Effect of Metronidazole on the Pathogenicity of Resistant Bacteroides Strains in Gnotobiotic Mice
Claudio Galuppo Diniz, Denise Carmona Cara, Jacques Robert Nicoli, Luiz De Macedo Farias, Maria Auxiliadora Roque De Carvalho
Antimicrobial Agents and Chemotherapy Sep 2000, 44 (9) 2419-2423; DOI: 10.1128/AAC.44.9.2419-2423.2000
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Anti-Bacterial Agents
Bacteroides
Bacteroides Infections
metronidazole

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596